EdgarLookup

Vistagen Therapeutics, Inc. — All Filings

868 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 10KSB 10QSB 3 3/A 4 4/A 424B3 424B4 424B5 5 8-A12B 8-A12G 8-K 8-K/A CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A EFFECT FWP NT 10-K NT 10-Q POS AM PRE 14A PRER14A RW S-1 S-1/A S-3 S-3/A S-8 S-8 POS SB-2 SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SC 14F1/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
4 0001415889-22-002294 Mar 3, 2022 Mar 1, 2022
SC 13G/A 0000935836-22-000196 Feb 15, 2022
SC 13G/A SC 13G/A 0001104659-22-022889 Feb 14, 2022
SC 13G/A AMENDMENT NO. 1 0000947871-22-000218 Feb 11, 2022
8-K FORM 8-K 0001437749-22-003012 Feb 10, 2022
10-Q FORM 10-Q 0001437749-22-003009 Feb 10, 2022 Dec 31, 2021
SC 13G 0000834237-22-007125 Feb 4, 2022
4 0001415889-22-000507 Jan 12, 2022 Jan 11, 2022
4 0001415889-22-000046 Jan 3, 2022 Dec 31, 2021
4 0001415889-22-000034 Jan 3, 2022 Dec 31, 2021
4 0001415889-22-000038 Jan 3, 2022 Dec 31, 2021
4 0001415889-22-000041 Jan 3, 2022 Dec 31, 2021
CT ORDER 9999999997-21-005725 Nov 16, 2021
10-Q FORM 10-Q 0001437749-21-026161 Nov 10, 2021 Sep 30, 2021
8-K FORM 8-K 0001437749-21-026182 Nov 10, 2021
8-K FORM 8K 0001654954-21-011105 Oct 15, 2021 Oct 14, 2021
8-K PRIMARY DOCUMENT 0001654954-21-010839 Oct 5, 2021
S-8 REGISTRATION STATEMENT 0001654954-21-010401 Sep 24, 2021
8-K PRIMARY DOCUMENT 0001654954-21-010193 Sep 17, 2021
8-K CURRENT REPORT 0001654954-21-009957 Sep 13, 2021
4 0001415889-21-004287 Sep 8, 2021 Sep 7, 2021
4 0001415889-21-004226 Sep 3, 2021 Aug 23, 2021
4 0001415889-21-004002 Aug 18, 2021 Aug 17, 2021
8-K PRIMARY DOCUMENT 0001654954-21-008859 Aug 12, 2021
10-Q QUARTERLY REPORT 0001654954-21-008845 Aug 12, 2021 Jun 30, 2021
DEF 14A DEFINITIVE PROXY STATEMENT 0001654954-21-008334 Jul 29, 2021 Sep 17, 2021
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001654954-21-008336 Jul 29, 2021
4 0001415889-21-003674 Jul 22, 2021 Jul 21, 2021
8-K CURRENT REPORT 0001654954-21-008125 Jul 22, 2021 Jul 21, 2021
3 0001415889-21-003672 Jul 22, 2021 Jul 21, 2021
8-K CURRENT REPORT 0001654954-21-008103 Jul 21, 2021 Jul 15, 2021
8-K CURRENT REPORT 0001654954-21-007757 Jul 8, 2021 Jul 6, 2021
3 0001415889-21-003542 Jul 7, 2021 Jul 6, 2021
4 0001415889-21-003544 Jul 7, 2021 Jul 6, 2021
4 0001415889-21-003388 Jul 2, 2021 Jun 30, 2021
4 0001415889-21-003387 Jul 2, 2021 Jun 30, 2021
4 0001415889-21-003391 Jul 2, 2021 Jun 30, 2021
4 0001415889-21-003389 Jul 2, 2021 Jun 30, 2021
10-K ANNUAL REPORT 0001654954-21-007380 Jun 29, 2021 Mar 31, 2021
8-K CURRENT REPORT 0001654954-21-007382 Jun 29, 2021
8-K CURRENT REPORT 0001654954-21-006979 Jun 17, 2021 Jun 16, 2021
8-K CURRENT REPORT 0001654954-21-006883 Jun 15, 2021 Jun 14, 2021
8-K CURRENT REPORT 0001654954-21-006329 May 27, 2021 May 26, 2021
424B5 PROSPECTUS SUPPLEMENT 0001654954-21-005699 May 14, 2021
8-K CURRENT REPORT 0001654954-21-005701 May 14, 2021
8-K CURRENT REPORT 0001654954-21-005102 May 4, 2021 May 1, 2021
4 0001415889-21-002243 May 4, 2021 May 1, 2021
SC 13D/A GROWTH EQUITY OPPORTUNITIES 17, LLC -- VISTAGEN--SCH 13D/A(#1) 0001072613-21-000386 Apr 29, 2021
4 0001415889-21-002138 Apr 27, 2021 Apr 23, 2021
4 0001415889-21-002139 Apr 27, 2021 Apr 23, 2021